Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Paul Hudson
CEOPaul Hudson
Employees
84,587
Employees84,587
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
84,587
Employees84,587

SNY Key Statistics

Market cap
115.85B
Market cap115.85B
Price-Earnings ratio
11.74
Price-Earnings ratio11.74
Dividend yield
3.39%
Dividend yield3.39%
Average volume
3.46M
Average volume3.46M
High today
$47.36
High today$47.36
Low today
$46.10
Low today$46.10
Open price
$46.27
Open price$46.27
Volume
2.21M
Volume2.21M
52 Week high
$60.12
52 Week high$60.12
52 Week low
$44.62
52 Week low$44.62

SNY News

TipRanks 1d
Sanofi Advances Amlitelimab Toward Global Filings After Positive Phase 3 Atopic Dermatitis Data

Claim 50% Off TipRanks Premium Sanofi ( (SNY) ) just unveiled an update. On January 23, 2026, Sanofi reported new phase 3 data showing that its investigationa...

Benzinga 1d
Sanofi Plans Regulatory Filings For Dupixent's Successor Despite Mixed Data From Pivotal Studies

On Friday, Sanofi SA (NASDAQ:SNY) shared data from two global phase 3 studies of amlitelimab, a fully human non-T cell depleting monoclonal antibody that select...

Sanofi Plans Regulatory Filings For Dupixent's Successor Despite Mixed Data From Pivotal Studies
The Wall Street Journal 2d
Sanofi Says Its Amlitelimab Drug Showed Promising Results in Treating Eczema

Guillaume Souvant/Agence France-Presse/Getty Images Sanofi SAN 1.73 %increase; green up pointing triangle said its amlitelimab drug confirmed its potential to...

Sanofi Says Its Amlitelimab Drug Showed Promising Results in Treating Eczema

Analyst ratings

67%

of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.